全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Paul L. Hess , Thomas M. Maddox , P. Michael Ho
来源:[J].BMC Cardiovascular Disorders(IF 1.457), 2017, Vol.17 (1)
摘要:The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its routine use in real world practice. We sought to describe adherence patterns and the association betwe...
作者:Thomas M. Maddox , Jason H. Wasfy
来源:[J].The American Journal of Cardiology(IF 3.209), 2020, Vol.125 (3), pp.354-361
摘要:Acute coronary syndrome (ACS) admissions are common and costly. The association between comprehensive ACS care pathways, outcomes, and costs are lacking. From 434,172 low-risk, uncomplicated ACS patients eligible for early discharge (STEMI 35%, UA/NSTEMI 65%) from the Premie...
作者:Thomas M. Maddox , Kevin Kennedy
来源:[J].The American Journal of Cardiology(IF 3.209), 2020
摘要:ABSTRACT(#br)Direct oral anticoagulants (DOACs) have a favorable bleeding risk profile in patients with atrial fibrillation (AF). However, the safety of individual DOACs relative to warfarin for specific bleeding outcomes is less certain. We identified 423,450 patients with ...
作者:Thomas M. Maddox , Javier A. Valle ...
来源:[J].The American Journal of Cardiology(IF 3.209), 2020, Vol.125 (1), pp.63-67
摘要:The 2018 resistant hypertension scientific statement offers new treatment recommendations. To determine the implications of these changes, we sought to ascertain the prevalence of apparent treatment resistant hypertension (aTRH) and the therapies used to treat it in an US na...
作者:Thomas M. Maddox , Anil Gehi ...
来源:[J].American Heart Journal(IF 4.497), 2018, Vol.195, pp.50-59
摘要:Background(#br)It is poorly understood whether insurance type may be a major contributor to the underuse of oral anticoagulation (OAC) among patients with atrial fibrillation (AF), particularly for novel oral anticoagulants (NOACs).(#br)Methods(#br)We performed a retrospecti...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×